Visakorpi T - Search Results

1

Generation of a conditionally replicating adenovirus based on targeted destruction of E1A mRNA by a cell type-specific MicroRNA.

Ylösmäki E, Hakkarainen T, Hemminki A, Visakorpi T, Andino R, Saksela K. Ylösmäki E, et al. Among authors: visakorpi t. J Virol. 2008 Nov;82(22):11009-15. doi: 10.1128/JVI.01608-08. Epub 2008 Sep 17. J Virol. 2008. PMID: 18799589 Free PMC article.

2

Primary cutaneous T-cell lymphomas show a deletion or translocation affecting NAV3, the human UNC-53 homologue.

Karenko L, Hahtola S, Päivinen S, Karhu R, Syrjä S, Kähkönen M, Nedoszytko B, Kytölä S, Zhou Y, Blazevic V, Pesonen M, Nevala H, Nupponen N, Sihto H, Krebs I, Poustka A, Roszkiewicz J, Saksela K, Peterson P, Visakorpi T, Ranki A. Karenko L, et al. Among authors: visakorpi t. Cancer Res. 2005 Sep 15;65(18):8101-10. doi: 10.1158/0008-5472.CAN-04-0366. Cancer Res. 2005. PMID: 16166283

3

ETS1 mediates MEK1/2-dependent overexpression of cancerous inhibitor of protein phosphatase 2A (CIP2A) in human cancer cells.

Khanna A, Okkeri J, Bilgen T, Tiirikka T, Vihinen M, Visakorpi T, Westermarck J. Khanna A, et al. Among authors: visakorpi t. PLoS One. 2011 Mar 22;6(3):e17979. doi: 10.1371/journal.pone.0017979. PLoS One. 2011. PMID: 21445343 Free PMC article.

4

MicroRNA expression profiling in prostate cancer.

Porkka KP, Pfeiffer MJ, Waltering KK, Vessella RL, Tammela TL, Visakorpi T. Porkka KP, et al. Among authors: visakorpi t. Cancer Res. 2007 Jul 1;67(13):6130-5. doi: 10.1158/0008-5472.CAN-07-0533. Cancer Res. 2007. PMID: 17616669

5

MiR-1247-5p is overexpressed in castration resistant prostate cancer and targets MYCBP2.

Scaravilli M, Porkka KP, Brofeldt A, Annala M, Tammela TL, Jenster GW, Nykter M, Visakorpi T. Scaravilli M, et al. Among authors: visakorpi t. Prostate. 2015 Jun;75(8):798-805. doi: 10.1002/pros.22961. Epub 2015 Mar 1. Prostate. 2015. PMID: 25731699

6

Epigenetically altered miR-193b targets cyclin D1 in prostate cancer.

Kaukoniemi KM, Rauhala HE, Scaravilli M, Latonen L, Annala M, Vessella RL, Nykter M, Tammela TL, Visakorpi T. Kaukoniemi KM, et al. Among authors: visakorpi t. Cancer Med. 2015 Sep;4(9):1417-25. doi: 10.1002/cam4.486. Epub 2015 Jul 1. Cancer Med. 2015. PMID: 26129688 Free PMC article.

7

Overexpression and gene amplification of BAG-1L in hormone-refractory prostate cancer.

Mäki HE, Saramäki OR, Shatkina L, Martikainen PM, Tammela TL, van Weerden WM, Vessella RL, Cato AC, Visakorpi T. Mäki HE, et al. Among authors: visakorpi t. J Pathol. 2007 Aug;212(4):395-401. doi: 10.1002/path.2186. J Pathol. 2007. PMID: 17503439

8

Mapping the amplification of EIF3S3 in breast and prostate cancer.

Nupponen NN, Isola J, Visakorpi T. Nupponen NN, et al. Among authors: visakorpi t. Genes Chromosomes Cancer. 2000 Jun;28(2):203-10. Genes Chromosomes Cancer. 2000. PMID: 10825005

9

Molecular cytogenetics of prostate cancer.

Nupponen NN, Visakorpi T. Nupponen NN, et al. Among authors: visakorpi t. Microsc Res Tech. 2000 Dec 1;51(5):456-63. doi: 10.1002/1097-0029(20001201)51:5<456::AID-JEMT8>3.0.CO;2-H. Microsc Res Tech. 2000. PMID: 11074616 Review.

10

Chromosomal aberrations in prostate cancer xenografts detected by comparative genomic hybridization.

Laitinen S, Karhu R, Sawyers CL, Vessella RL, Visakorpi T. Laitinen S, et al. Among authors: visakorpi t. Genes Chromosomes Cancer. 2002 Sep;35(1):66-73. doi: 10.1002/gcc.10097. Genes Chromosomes Cancer. 2002. PMID: 12203791

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

293 results

Search Page